Michael L. Marotta

Clinical Research Associate

Michael joined IMARC after working for eight years in the laboratory of Hisashi Tanaka in the Department of Molecular Genetics at the Cleveland Clinic Foundation. While at the Cleveland Clinic, he worked on evaluating the role of palindromes in gene amplification and the implications on tumor development, pathogenesis, drug resistance, and genome variation/evolution. More specifically, he focused on taking innovative Next Generation Sequencing, genomic, and cytogenic approaches to identify risk alleles and tumor origins for common cancers such as colorectal cancer and ERBB2 positive breast cancer. Prior to that, he worked in the laboratory of Dr. Miguel Quinones-Mateu developing novel approaches towards human immunodeficiency virus type 1 (HIV-1) fitness and antiretroviral strategies. While there he received his Masters of Science in Biology for development and testing of lethal mutagenesis as an antiviral strategy against HIV-1. He has had the opportunity to present his work at both National and Local Scientific Conferences, publish his results in leading Scientific journals, and his research has been funded by the National Institute of Health.

Michael joined IMARC in February 2014 and has monitored studies investigating treatments for thoracic aneurysms, ulcers, internal iliac artery patency, and acute MI diagnostics. His diverse background in working in a wide array of scientific fields, large datasets, and utilizing innovative approaches to tackle complex diseases has aided him in tackling new projects and providing fresh insight when monitoring clinical studies. His ability to distill complex information into simple concepts allows him to work well with sites to follow challenging protocols. In addition, he strives to maintain open communication between sites and sponsors in order to leverage the needs of both while maintaining perspective on additional non-study related responsibilities of each. When he is not monitoring clinical trials, Michael enjoys staying current on new trends in medical devices, personalized medicine, and FDA Guidances.

Michael received both his Masters Degree and Undergraduate Degree in Biology at John Carroll University in University Heights, Ohio.